Recursion Pharmaceuticals (RXRX): Best AI Stocks Under $50 to Buy Right Now

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks under $50 to buy right now. On May 6, Recursion reported significant progress across its AI-driven clinical pipeline for Q1 2026, highlighted by positive early data for its RBM39 degrader, REC-1245. In the Phase 1/2 DAHLIA study, the molecule showed a well-tolerated safety profile with no dose-limiting toxicities and predictable, dose-dependent pharmacokinetics.

Additionally, the company dosed the first patient in its Phase 1 study of REC-4539, a reversible LSD1 inhibitor designed to avoid the platelet toxicity common in similar treatments. These milestones underscore the company’s ability to use its “full stack” OS to rapidly translate biological insights into differentiated clinical candidates.

The company’s advanced programs also reached critical inflection points, particularly REC-4881 for familial adenomatous polyposis/FAP. Following positive Phase 2 data that showed a 53% reduction in polyp burden, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) initiated engagement with the FDA to define a potential registrational pathway, with a formal update expected in H2 2026. The company continues to advance large-scale “maps of biology” with Roche and Genentech, using over 1 trillion internally manufactured neuronal cells to identify novel targets in oncology and immunology.

Recursion Pharmaceuticals (RXRX): Best AI Stocks Under $50 to Buy Right Now

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is a Utah-based clinical-stage biotech company that specializes in the decoding of biology and chemistry. The company develops its solutions by integrating technological advancements in AI and ML to accelerate drug discovery.

While we acknowledge the risk and potential of RXRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than RXRX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.